EU biocidal product registry upgrade announced

Published: 2-Jul-2015
Regulatory

R4BP 3.3 now has updated functionalities to help both industry and authorities make better use of their time, multitask, and meet their regulatory obligations


A new user-friendly version of the European Chemical Agency’s (ECHA) biocidal product registration database has been launched. Called R4BP 3.3, this IT system, through which all biocidal product authorisation applications are made under the EU biocidal products registration, now has updated functionalities. These are designed to help both industry and authorities make better use of their time, multitask, and meet their regulatory obligations.

Changes include offering international support for usernames and more specific error messages to inform users what went wrong; improvements to how summaries of product characteristics (SPC) are logged and handled – as finalised SPCs can now be downloaded as PDFs; and improvements to the transfer of simplified authorisations by allowing all related ongoing and finalised notifications to be transferred to a new authorisation holder.

According to the ECHA, the new version also 'removes the limitation regarding the authorisation holders for ‘same biocidal product’ authorisations: the same company can hold the initial authorisation and a related same biocidal product authorisation at the same time for the same market area.

'It also enables the use of Annex I active substance assets to start new product authorisation applications. Annex I is a list of initially active substances that present a low risk, substances identified as food additives, pheromones and other substances considered to have low toxicity, such as weak acids, alcohols and vegetable oils used in cosmetics and food.

R4BP 3 should help 'the industry and the authorities to comply with the legislative requirements,' said the ECHA. There are two user interfaces on the system: one for the industry and one for authorities, and the system allows for the exchange of information between them.

  • Companies:
  • ECHA European Chemicals Agency
See more

You may also like

Ingredients

ECHA releases new chemical classification and labelling database

Read more
Aims to improve how ECHA makes this information available

Trending Articles

  1. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  3. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  4. The rising importance of preservative efficacy testing When considering the regulation and validation of pharmaceutical products, the efficacy of the active pharmaceutical ingredient (API) is often the main concern
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Ingredients

ECHA releases new chemical classification and labelling database

Aims to improve how ECHA makes this information available
Regulatory

New EU regulation for export and import of hazardous chemicals comes into operation

ECHA takes over responsibility for the technical and administrative aspects of PIC
Regulatory

ECHA opens up over biocides but users are unconvinced

Companies need to know which products they will keep in their portfolios, whether they can group products (for approval), and that the same approach will be taken at national and (European) Union level
Ingredients

ECHA increases REACH fees

SMEs will continue to pay less than larger companies
Ingredients

ECHA probes safety of cobalt salts used in pharma

EC will use findings to decide whether ECHA should draft use restrictions
Ingredients

REACH review recommends cutting registration fees for SMEs

Improvements need to be made to quality of registration dossiers, says EC report
Regulatory

ECHA to allow third parties to make REACH filings

Change in rules will be introduced in the summer
Subscribe now